Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Nyxoah S A (NYXH)

Nyxoah S A (NYXH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 243,414
  • Shares Outstanding, K 24,940
  • Annual Sales, $ 4,710 K
  • Annual Income, $ -46,770 K
  • 60-Month Beta 1.58
  • Price/Sales 58.58
  • Price/Cash Flow N/A
  • Price/Book 1.88
Trade NYXH with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.45
  • Number of Estimates 4
  • High Estimate -0.40
  • Low Estimate -0.49
  • Prior Year -0.49
  • Growth Rate Est. (year over year) +8.16%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.28 +17.80%
on 04/15/24
12.79 -23.69%
on 04/08/24
-2.75 (-21.98%)
since 04/03/24
3-Month
8.28 +17.80%
on 04/15/24
20.00 -51.20%
on 03/18/24
-1.41 (-12.66%)
since 02/02/24
52-Week
4.00 +144.00%
on 01/17/24
20.00 -51.20%
on 03/18/24
+1.66 (+20.49%)
since 05/03/23

Most Recent Stories

More News
Syneos Health (SYNH) Q1 Earnings and Revenues Surpass Estimates

Syneos Health (SYNH) delivered earnings and revenue surprises of 11.94% and 6.17%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

SYNH : 42.98 (+0.02%)
NYXH : 9.76 (-1.71%)
Senseonics Holdings (SENS) Reports Q1 Loss, Tops Revenue Estimates

Senseonics (SENS) delivered earnings and revenue surprises of 0% and 35.86%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

SENS : 0.5049 (-2.55%)
NYXH : 9.76 (-1.71%)
Privia Health (PRVA) Surpasses Q1 Earnings and Revenue Estimates

Privia Health (PRVA) delivered earnings and revenue surprises of 100% and 2.14%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

PRVA : 18.74 (+1.79%)
NYXH : 9.76 (-1.71%)
Strength Seen in Nyxoah SA (NYXH): Can Its 10.2% Jump Turn into More Strength?

Nyxoah SA (NYXH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road....

NYXH : 9.76 (-1.71%)
FLGT : 21.50 (+1.22%)
Wall Street Analysts See a 240% Upside in Nyxoah SA (NYXH): Can the Stock Really Move This High?

The mean of analysts' price targets for Nyxoah SA (NYXH) points to a 240% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts...

NYXH : 9.76 (-1.71%)
Nyxoah S.A. (NYXH) Q2 2022 Earnings Call Transcript

NYXH earnings call for the period ending June 30, 2022.

NYXH : 9.76 (-1.71%)
Nyxoah Reports Second Quarter and First Half 2022 Financial and Operating Results

REGULATED INFORMATION Nyxoah Reports Second Quarter and First Half 2022 Financial and Operating Results DREAM enrollment complete, 12-month clinical data...

NYXH : 9.76 (-1.71%)
CareCloud, Inc. (MTBC) Reports Q2 Loss, Lags Revenue Estimates

CareCloud, Inc. (MTBC) delivered earnings and revenue surprises of 46.15% and 0.66%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

MTBC : 3.13 (+12.19%)
NYXH : 9.76 (-1.71%)
Nyxoah and Acurable Enter into Distribution Agreement in Germany for the AcuPebble SA100 Home Sleep Test

Nyxoah and Acurable Enter into Distribution Agreement in Germany for the AcuPebble SA100 Home Sleep Test Mont-Saint-Guibert, Belgium – August 2, 2022,...

NYXH : 9.76 (-1.71%)
Nyxoah to Present at the Canaccord Genuity 42nd Annual Growth Conference

Nyxoah to Present at the Canaccord Genuity 42nd Annual Growth Conference Mont-Saint-Guibert, Belgium – July 27, 2022, 10:30pm CET / 4:30pm ET –...

NYXH : 9.76 (-1.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium.

See More

Key Turning Points

3rd Resistance Point 11.17
2nd Resistance Point 10.83
1st Resistance Point 10.30
Last Price 9.76
1st Support Level 9.43
2nd Support Level 9.09
3rd Support Level 8.56

See More

52-Week High 20.00
Fibonacci 61.8% 13.89
Fibonacci 50% 12.00
Fibonacci 38.2% 10.11
Last Price 9.76
52-Week Low 4.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar